Emmessar Biotech And Nutrition (BOM:524768) Total Current Assets : ₹74.06 Mil (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Emmessar Biotech And Nutrition's total current assets for the quarter that ended in Mar. 2025 was ₹74.06 Mil.

Emmessar Biotech And Nutrition Total Current Assets Historical Data

The historical data trend for Emmessar Biotech And Nutrition's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emmessar Biotech And Nutrition Total Current Assets Chart

Emmessar Biotech And Nutrition Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Current Assets

Get a 7-Day Free Trial

53.94

48.61

59.34

68.32

74.06

Emmessar Biotech And Nutrition Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Current Assets	Get a 7-Day Free Trial															68.32	-	74.19	-	74.06

Emmessar Biotech And Nutrition Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Emmessar Biotech And Nutrition's Total Current Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	71.412	+	0.483	+	1.238	+	0.92899999999999
	=	74.06

Emmessar Biotech And Nutrition's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	71.412	+	0.483	+	1.238	+	0.92899999999999
	=	74.06

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Emmessar Biotech And Nutrition (BOM:524768) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Emmessar Biotech And Nutrition's Liquidation Value for the quarter that ended in Mar. 2025 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	71.412	-	15.12	+	0.75 * 0.178	+	0.5 * 1.238
=	57.04

Emmessar Biotech And Nutrition Total Current Assets Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmessar Biotech And Nutrition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » Total Current Assets

Traded in Other Exchanges

N/A

Address

38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001

Website

https://www.ebnl.org

Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines